Mayo Clinic

Expert Alert: Encephalitis prevention another reason to receive COVID-19 vaccine

Newswise — ROCHESTER, Minn. ― Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain.

"Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare complication," says Michel Toledano, M.D., a Mayo Clinic neurologist.

In the case of encephalitis caused by communicable diseases for which there is a vaccine available, getting vaccinated is the best way of preventing the disease.

"It is important for the public to know that COVID-19 is now a vaccine-preventable disease. The best way to avoid developing potential neurologic complications from COVID-19 is to not get the virus in the first place," Dr. Toledano says.

Monday, Feb. 22, is World Encephalitis Day. In recognition, the Plummer Building in Rochester, Minnesota; Mayo Clinic Hospital in Arizona; and the sign at the main entrance to Mayo Clinic in Florida will be lighted red beginning at sunset. The Encephalitis Society’s Lights Camera Action campaign will light landmarks worldwide, including Niagara Falls in Ontario and Tower 42 in London.

Encephalitis affects nearly 500,000 people of all ages worldwide each year, according to the Encephalitis Society. The inflammation can be caused by an infection invading the brain, but it also can be caused by the immune system attacking the brain in error, called autoimmune encephalitis. Sometimes the immune attack can be triggered by an infection in the body without the infection itself invading the brain.

Symptoms of encephalitis evolve over days to weeks and include fever, confusion, headache, vomiting, weakness and seizures.

"This is a very serious condition; encephalitis can lead to coma and death,” says Sebastian Lopez, M.D., a Mayo Clinic neurologist. "Early diagnosis and prompt treatment are critical for achieving better neurologic outcomes. Diagnosing the exact cause of encephalitis is important because treatments vary, depending on whether patients have an underlying infection or a reaction caused by the immune system."

Despite significant progress, encephalitis is still associated with high mortality. Those who recover from the initial illness may struggle with fatigue, paralysis, language impairment, personality changes and memory problems that may persist for months or permanently.

"The recovery process can be very challenging for those who are struggling with the residual effects of a disease process that family and friends often do not understand," says Marie Grill, M.D., a Mayo Clinic neurologist. "Increased awareness of encephalitis can help these patients be better supported."

In 2006, Mayo Clinic created the nation’s first autoimmune neurology clinic specializing in the diagnosis and treatment of encephalitis. Mayo Clinic’s Clinical Neuroimmunology Laboratory tests more than 150,000 patients annually for antibodies targeting the nervous system.

###

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.



Filters close

Showing results

110 of 5869
Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Released: 23-Jun-2021 3:55 PM EDT
Cooperative Extension grant aims to vaccinate NYS’ vulnerable
Cornell University

A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell University researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.

Released: 23-Jun-2021 12:10 PM EDT
Phone swabs can accurately detect COVID-19
University College London

An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.

Newswise: NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
Released: 23-Jun-2021 11:35 AM EDT
NIH study suggests COVID-19 prevalence far exceeded early pandemic cases
National Institute of Biomedical Imaging and Bioengineering

In a new study, NIH researchers report that the prevalence of COVID-19 in the United States during spring and summer of 2020 far exceeded the known number of cases and that infection affected the country unevenly.


Showing results

110 of 5869

close
1.92659